Tirzepatide 54568-0170
Product NDC
54568-0170- Manufacturer
- Eli Lilly Italia Spa
- Dosage Form
- Injection, Solution
- Product Type
- Drug For Further Processing
- Marketing Start
- August 12, 2022
- Listing Expires
- December 31, 2026
Active Ingredients
| Ingredient | Strength |
|---|---|
| Tirzepatide | 2.5 mg/.5mL |
Packaging Options(1)
160 SYRINGE in 1 TRAY (54568-170-17) / .5 mL in 1 SYRINGE